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Abstract 
BACKGROUND: Diabetic neuropathy is one of the most complicated complications of diabetes patients with 
Type 2 diabetes. 
AIM: The purpose of this study was to determine the diagnosis of diabetic neuropathy based on Clinical 
Neurological Examination (CNE) and the factors that influence the occurrence of diabetic neuropathy in Type 2 
DM patients at Amplas Primary Health Care (PHC) in Medan City. 
METHODS: The research design was descriptive-analytic with the cross-sectional approach. The study 
population was all Type 2 DM patients who came to Amplas PHC with a total sample of 53 people using the 
consecutive sampling. The research data source is primary data, namely the assessment of diabetic neuropathy 
using the Clinical Neurological Examination (CNE) criteria. Data were processed using SPSS and analysis using 
the chi-square test. 
RESULTS: The results showed the majority of Type 2 DM patients had mild neuropathy as many as 24 people 
(45.3%). The Chi-square test results showed there was a relationship between age and duration of diabetes with 
the incidence of diabetic neuropathy in Type 2 DM patients at Amplas Primary Health Care. 
CONCLUSION: Education and early detection with proper management can prevent more severe complications 
so that the quality of life of patients can be maintained better. 
 
 
 
 
 
 
Introduction 
 
Diabetic neuropathy is one of the 
macrovascular complications in Type 2 DM patients; 
this can occur due to uncontrolled blood sugar in 
diabetic patients, the more uncontrolled, the faster the 
neuropathy complaints [1]. 
Diabetic neuropathy is one of the chronic 
diabetes complications. People with diabetes have 11 
times riskier of developing neuropathy compared to 
those without diabetes [2]. Some study found the most 
cases of neuropathy above the age of 55 years. 
People with DM have peripheral neuropathy as much 
as 25% of all people with diabetes mellitus in the 
world [3]. In the United States, 60-70% of diabetic 
patients (T2DM) have complications of diabetic 
neuropathy [4]. In Indonesia, experienced neuropathy 
in 43% of 16.800 patients Types 2 DM who were 
proven to be at risk of developing neuropathy [5]. 
Symptoms of neuropathy in patients with 
Type 2 DM such as numbness, burning, pricking, and 
other problems are often complained of but rarely 
noticed. Patients rarely treat neuropathy because they 
do not know the symptoms, and this problem can 
interfere with the quality of life of patients. Some study 
reported that out of a total of 4097 patients, 90.6% 
had type 2 diabetes. Among that 90.6 %, those with 
complications of diabetic neuropathy were 19.4%, 
followed by other complications of DM such as erectile 
dysfunction by 17. 5% and diabetic retinopathy of 
16.8% [2]. 
Neuropathy is a serious health problem in 
patients with Type 2 DM because it can cause 
disruption of function and can even cause disability. 
Peripheral neuropathy can impact on muscle 
weakness and loss of reflex, especially at the ankles. 
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This situation results in changes in the way of walking 
and changes in the shape of the legs, such as 
hammertoes. As a result of suppression or injury to 
areas that experience numbness, often ulcers arise in 
the legs of patients with peripheral diabetic 
neuropathy, if it is not handled correctly, an infection 
can occur that spreads to the bone so it must be 
amputated [6]. 
Prevention of worsening of neuropathy can be 
done by early prevention. One form of early 
prevention is by examining peripheral neuropathy. 
Early detection of neuropathy is essential in DM 
patients, and preventive interventions can be applied 
to reduce morbidity. Clinical Neurological Examination 
(CNE) is used to detect and diagnose diabetic 
neuropathy in daily clinical practice. CNE includes a 
study of sensory function, leg muscle strength, ankle 
reflexes, and a specific score for each examination 
[7]. 
The Clinical Neurological Examination (CNE) 
is a scoring system that is used to assess sensory 
disorders and reflexes in the lower limbs. Clinical 
assessment is done to determine the presence or 
absence of neurological disorders, including sensory 
tests, tot strength, and ankle reflexes. Recently CNE 
has been used to detect and diagnose diabetic 
neuropathy in daily clinical practice. CNE is one 
modification of NDS because of the Neuropathy 
Disability Score (NDS), considered to be more 
complicated and challenging to apply in practical 
clinical use. Clinical Neurological Examination 
includes studies of sensory function, leg muscle 
strength, ankle reflexes, and the giving of sure scores 
for each examination. 
The purpose of this study was to determine 
the diagnosis of diabetic neuropathy based on Clinical 
Neurological Examination (CNE) and the factors that 
influence the occurrence of neuropathy in Type 2 DM 
patients at Amplas Primary Health Care in Medan 
City. 
 
 
Material and Methods 
 
 The study was descriptive-analytic (cross-
sectional approach). The population of the study was 
all Type 2 DM patients who came to the Amplas 
Primary Health Care from January to March 2019. 
The participation of patients was voluntary by signing 
informed consent. Sampling was carried out by 
consecutive sampling with inclusion and exclusion 
criteria. Inclusion criterion is Diabetes patients 
residing in the Amplas PHC area, patients who come 
independently to the PHC, while the inclusion criteria 
are patients with a history of previous neuropathy 
(e.g., heavy smokers, known blood vessel blockage 
diseases from anamneses), patients who have 
experienced heart attack, patients who have had heart 
surgery. 
 The source of study data is Primary data. 
Neuropathy assessment is based on CNE criteria, 
where sensory tests, muscle strength, and ankle 
reflexes are assessed on both right and left limbs. The 
results of the examination are determined by scoring if 
the measurement is in normal condition the score is 0, 
decreases are 1, and a negative score is 2. The 
overall score for CNE examination ranges from 0 to 
37 points. The total score is then categorised. Score 0 
= no neuropathy, score 1-9 = mild degree, score 10 - 
18 = moderate degree, while score 19-33 = severe 
degree. The data is processed using computer SPPS 
to assess the factors that influence the occurrence of 
diabetic neuropathy by doing the chi-square test. 
 
 
Results  
 
Baseline Characteristics of Type 2 Diabetic 
 Patients 
The result of Table 1 shows that the majority 
of patients aged 51-60 years as many as 25 people 
(47.2%), DM patients at most are female as many as 
36 people (67.9%), based on the duration of diabetes 
it is known that most DM patients have 3-5 years and 
more than 5 years 19 people (35.8%). 
Table 1: Basic Characteristics of T2DM patients 
Characteristics Frequency (n) Percentage (%) 
Age (years)   
40-50 19 35.8 
51-60 25 47.2 
61-70 8 15.1 
> 70 1 1.9 
Gender   
Male 17 32.1 
Female 36 67.9 
Duration Suffering DM    
< 3 years 15 28.4 
3-5 years 19 35.8 
> 5 years 19 35.8 
Family History    
Father 10 18.9 
Mother 15 28.3 
Father and Mother  2 3.8 
No one  26 49.0 
Neuropathy (based on CNE Score)   
Normal (score 0)  18 34 
MildNeuropathy (score1-9)  24 45.3 
Moderate Neuropathy (Score10-18)  8 15.0 
Severe Neuropathy (Score 19-32)  3 5.7 
 
The majority of patients did not have a family 
history of diabetes as many as 26 people (49.0%). 
Based on the assessment, it is known that most 
patients have mild neuropathy of 24 people (45.3%). 
 
Factors influence the Prevalence of 
 Diabetic Neuropathy 
Based on Table 2 shows that severe 
neuropathy is found in the age group of 40-50 as 
many as 2 people (10.6%) while moderate neuropathy 
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is located in the age group 51-60 years as many as 12 
people (48.0%), based on chi-square test result that 
age and duration of diabetes have relationship with 
peripheral neuropathy experienced by Type 2 DM 
patients (p < 0.05). 
Table 2: Factors that influence the occurrence of Diabetic 
Neuropathy 
Risk Factors Normal Mild Moderate Severe P 
Age (years)      
40-50 7 (36.8) 7 (36.8) 3 (15.8) 2 (10.6) 0.03 
51-60 8 (32.0) 12 (48.0) 4 (16.0) 1 (4)  
61-70 2 (25.0) 5 (62.5) 1 (12.5) 0 (0)  
> 70 1 (100) 0 (0) 0 (0) 0 (0)  
Gender      
Male 4 (23.5) 9 (52.9) 2 (11.8) 2 (11.8) 0.90 
Female 14 (38.9) 15 (41.7) 6 (16.7) 1 (2.7)  
Duration DM      
< 3 Years 8 (53.3) 7 (46.7) 0 (0) 0 (0) 0.04 
3-5 Years 8 (42.1) 11 (57.9) 0 (0) 0 (0)  
> 5 Years 2 (10.6) 6 (31.6) 8 (42.0) 3 (15.8)  
Family History       
Father 3 (30) 3 (30) 3 (30) 1 (10) 0.15 
Mother 6 (40) 5 (33.3) 3 (20) 1 (6.7)  
Both  1 (50) 0 (0) 0 (0) 1 (50)  
No One  8 (30.8) 16 (61.5) 2 (7.7) 0 (0)  
 
 
 
 
Discussion 
 
The study showed that there was a significant 
relationship between age and the prevalence of 
diabetic neuropathy. The results of this study are in 
line with other studies who get the most age in 
patients with diabetic neuropathy ranging from 51-60 
years [8], while another study states that diabetic 
neuropathy patients are more than 50 years old [9].  
In theory, it can be explained that increasing 
age stimulates the degeneration process and causes 
nerve cell damage. Changes in both large nerve fibres 
and small nerve fibres give rise to vulnerability in the 
elderly to neuropathy [4]. The number of patients with 
diabetic neuropathy in the age range of 45-65 years is 
due to the age of tissue damage caused by free 
radicals such as increased levels of lipid peroxide and 
changes in enzyme activity. Diabetes is degenerative, 
a disease that appears slowly along with the 
increasing age of the patient for years so that patients 
experience complications of diabetic neuropathy [10]. 
So that rising age will increase the risk of 
complications of diabetic neuropathy in diabetic 
patients [11]. 
Neuropathy based on gender is known to be 
more severe in male neuropathy (11.8%), while mild 
neuropathy is more common in female DM patients 15 
people (41.7%). The Chi-square statistical test 
showed that there was no correlation between the 
incidence of neuropathy and the gender of Type 2 DM 
patients (p < 0.05).  
The results of the study found that the 
prevalence of diabetic neuropathy was more prevalent 
in women ranging from 50.8% [4], [12]. Hormone 
differences in men and women affect the onset of 
neuropathy. High levels of oestrogen in women can 
interfere with the absorption of iodine, which plays a 
role in the process of nerve myelin formation while 
testosterone levels in men protect the body from type 
2 DM, but not in women [4].  
In general, in this study it can be seen that 
more women experience diabetic neuropathy than 
men, more women participating in this study can 
cause this no difference in the prevalence of diabetic 
neuropathy based on age in Type 2 DM patients at 
Amplas PHC.  
Majority duration of illness of diabetic patients 
> 5 years, the results of the Chi-square statistical test 
revealed that there was a relationship between the 
duration suffering of diabetes with neuropathy (p < 
0.05). 
This study is in line with by Tabatabaei-
Malazy where diabetic neuropathy sufferers are more 
common in people who have suffered DM for > 5 
years [13], while according to [4] the average age of 
diabetic neuropathy patients has experienced DM for 
10 year 
Diabetic neuropathy generally occurs after 5 
years of suffering from type 2 diabetes mellitus. Low 
glycemic control and dyslipidemia will increase the 
occurrence of diabetic neuropathy [14]. The more 
extended Type 2 DM, the higher the incidence of 
complications experienced. The duration of type 2 
diabetes mellitus with high blood sugar levels will 
affect changes in blood vessel walls [15]. Chronic high 
blood sugar levels cause a decrease in insulin 
secretion. Glucose will turn into sorbitol, which causes 
nerve cell damage. The longer a person suffers from 
DM, the process will last longer and worsen the 
occurrence of nerve cell damage [16]. 
The duration of suffering from diabetes 
causes chronic hyperglycemia in patients whose 
blood sugar levels are uncontrolled. Chronic 
hyperglycemia causes microangiopathy that underlies 
the onset of neuropathy. In patients newly diagnosed 
with DM, it was found that less than 10% had 
symptoms of clinical neuropathy [4].  
It was found that there were 16 people 
(61.5%) who had neuropathy without having a family 
history of DM, the Chi-square statistical tests stated 
that p = 0.15 (p > 0.05) means that there was no 
association between family history with neuropathy in 
Type 2 DM patients. 
This study is the same with another study 
where the higher prevalence of diabetic neuropathy 
was found in groups without a family history [12]. In 
theory, stated that family history relates to diabetes 
mellitus where if one parent suffers from DM, a 
person's risk of developing DM is 15% if both parents 
have diabetes, the risk of developing DM increases to 
75% [17]. Still, this research is not in line with the 
theory, possibly caused by the more significant role of 
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lifestyle in creating respondents in this study to be 
affected by DM. 
The genetic risk will increase two to six times 
if parents or siblings experience type 2 diabetes 
mellitus [18]. Someone who has a history of hereditary 
type 2 diabetes mellitus will increase the risk of type 2 
diabetes mellitus by 2-fold compared to someone who 
does not have a history of genetic type 2 diabetes 
mellitus. The result another study said the majority of 
female type 2 diabetes mellitus has a history of type 2 
diabetes mellitus [19], [20] In this study indicate that 
lifestyle is a significant risk of diabetes compared to 
genetic patients, because of all people with diabetes, 
it is known that 49% do not have a family history. 
In conclusions, diabetes neuropathy is one of 
the most common complications of microangiopathy 
experienced by Type 2 DM patients, from various 
factors known as age and family history, affecting the 
occurrence of diabetic neuropathy. Education and 
early detection with proper management can prevent 
more severe complications so that the quality of life of 
patients can be maintained better. 
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